Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target?
about
Zebrafish Models for Dyslipidemia and Atherosclerosis ResearchCarboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cellsSeven functional polymorphisms in the CETP gene and myocardial infarction risk: a meta-analysis and meta-regressionLow levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease.Tachometer for reverse cholesterol transport?Frail HDLs and stiff arteries in type 2 diabetes in juveniles.
P2860
Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Implications of torcetrapib fa ...... -cholesterol the right target?
@en
Implications of torcetrapib fa ...... -cholesterol the right target?
@nl
type
label
Implications of torcetrapib fa ...... -cholesterol the right target?
@en
Implications of torcetrapib fa ...... -cholesterol the right target?
@nl
prefLabel
Implications of torcetrapib fa ...... -cholesterol the right target?
@en
Implications of torcetrapib fa ...... -cholesterol the right target?
@nl
P2860
P356
P1476
Implications of torcetrapib fa ...... -cholesterol the right target?
@en
P2860
P304
P356
10.1586/ERC.10.6
P577
2010-03-01T00:00:00Z